Abstract
Full text links
Read article at publisher's site: https://doi.org/10.3233/jnd-219005
Read article for free, from open access legal sources, via Unpaywall:
https://content.iospress.com:443/download/journal-of-neuromuscular-diseases/jnd219005?id=journal-of-neuromuscular-diseases%2Fjnd219005
Citations & impact
Impact metrics
Alternative metrics
Discover the attention surrounding your research
https://www.altmetric.com/details/115443879
Article citations
Simvastatin and Muscle: Zebrafish and Chicken Show that the Benefits are not Worth the Damage.
Front Cell Dev Biol, 10:778901, 14 Mar 2022
Cited by: 1 article | PMID: 35359432 | PMCID: PMC8964290
Co-Administration of Simvastatin Does Not Potentiate the Benefit of Gene Therapy in the mdx Mouse Model for Duchenne Muscular Dystrophy.
Int J Mol Sci, 23(4):2016, 11 Feb 2022
Cited by: 6 articles | PMID: 35216132 | PMCID: PMC8878028
Similar Articles
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.
Author's Response to: Rebuttal to: Simvastatin Treatment Does Not Ameliorate Muscle Pathophysiology in a Mouse Model for Duchenne Muscular Dystrophy, Verhaart et al. 2020.
J Neuromuscul Dis, 8(5):867-868, 01 Jan 2021
Cited by: 1 article | PMID: 34542081
Simvastatin Treatment Does Not Ameliorate Muscle Pathophysiology in a Mouse Model for Duchenne Muscular Dystrophy.
J Neuromuscul Dis, 8(5):845-863, 01 Jan 2021
Cited by: 5 articles | PMID: 33044191 | PMCID: PMC8543260
Simvastatin does not alleviate muscle pathology in a mouse model of Duchenne muscular dystrophy.
Skelet Muscle, 11(1):21, 03 Sep 2021
Cited by: 10 articles | PMID: 34479633 | PMCID: PMC8414747
Therapeutic strategies to address neuronal nitric oxide synthase deficiency and the loss of nitric oxide bioavailability in Duchenne Muscular Dystrophy.
Orphanet J Rare Dis, 12(1):100, 25 May 2017
Cited by: 14 articles | PMID: 28545481 | PMCID: PMC5445371
Review
Free full text in Europe PMC
